跳至主要内容
临床试验/CTRI/2016/03/006712
CTRI/2016/03/006712已完成4 期

Evaluation of analgesic efficacy of dexmedetomidine as adjuvant with ropivacaine in adductor canal block(ACB).

Govt Medical College And Hospital0 个研究点目标入组 105 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
105

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. ASA physical status I and II of either sex
  • 2. Age between 18 to 60 years
  • 3. BMI >= 20 to <= 30 kg m-2
  • 4. Scheduled for ACL reconstruction surgery.

排除标准

  • 1. Patients having history of substance abuse.
  • 2. Patients with coagulopathy and bleeding disorders.
  • 3. Preexisting peripheral neuropathy.
  • 4. Preexisting local infection at the site of block.
  • 5. Pregnant and lactating women.
  • 6. Inability to understand functioning of PCA pump and VAS (Visual Analogue Scale).
  • 7. Contraindication to study drugs ropivacaine, dexmedetomidine and morphine.
  • 8. Patients having haemodynamic instability, hypotension, bradycardia, hepatic dysfunction.
  • 9. Patients on regular chronic pain management drugs for the last three months.

研究者

发起方
Govt Medical College And Hospital

相似试验